pubrio
Kerecis logo
Medical Devices700+ employeesFounded 2011🇮🇸 Iceland

Kerecis was founded by Fertram Sigurjonsson around the concept of using fish skin to heal damaged tissue. The company is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and regenerative medicine market. The fatty-acid rich (including Omega3) products from the company's patented technologies enable the body to regenerate tissues, rather than simply repair them and risk scarring. The Kerecis products are used to regenerate tissue in trauma and chronic wounds such as burns and diabetic wounds. Kerecis is also developing products for areas such as oral surgery, plastic surgery and neurological applications. The vision of Kerecis is to extend human life by supporting the body's own ability to regenerate. The Kerecis mission is to become the world leader in regenerating damage of the human body by sustainably harnessing nature's own remedies. In August 2023 Kerecis became Iceland's first Unicorn when it sold to the Danish company Coloplast for $1.3 Billion.

Founded
2011
Employees
700+
Industry
Medical Devices
Headquarters
🇮🇸Sundstraeti 36, Isafjordur, Vestfirdir 400, Is
Specialties
Medical Devices
1 / 1
Active markets
United States
0
New markets
Medium
Confidence
mostly early signals
+6700%
Momentum
vs prior period
65 / 100
Expansion Score
Strong
Stages1Expanding
NaN signals · Last 90 days

Global expansion

Live
United States
Stages
ExploringCommittingExpandingScaling

Activity pulse

New Marketing & PR activity — 68 fresh signals just appeared.

Last 90 days
Hiring
1Ended
Hiring
Marketing & PR
68New
Advertising
Product & Tech
0
No activity
+2more categoriesLocked
3 of 5 shown

Market entry timeline

The order this company entered each market — oldest to newest

1
🇺🇸United States1st market entered · 2023Advancing
Expanding
13 signalsExpanding stage
Current stageExpandingGrowing a local footprint
Confidence60%Medium
Tracking since2023first signal

Recent signals

Advertising🇫🇷 Francetoday

Advertising🇩🇪 Germanytoday

Sign up to see the full signal feed

Good to know

Frequently Asked Questions Regarding Kerecis

Quick answers about Kerecis's business, markets, and growth signals.

Kerecis was founded by Fertram Sigurjonsson around the concept of using fish skin to heal damaged tissue. The company is pioneering the use of fish skin and fatty acids in the globally expanding cellular therapy and regenerative medicine market. The fatty-acid rich (including Omega3) products from the company's patented technologies enable the body to regenerate tissues, rather than simply repair them and risk scarring. The Kerecis products are used to regenerate tissue in trauma and chronic wounds such as burns and diabetic wounds. Kerecis is also developing products for areas such as oral surgery, plastic surgery and neurological applications. The vision of Kerecis is to extend human life by supporting the body's own ability to regenerate. The Kerecis mission is to become the world leader in regenerating damage of the human body by sustainably harnessing nature's own remedies. In August 2023 Kerecis became Iceland's first Unicorn when it sold to the Danish company Coloplast for $1.3 Billion.

800M+
Companies watched
50+
Local data sources
16
Movement signals
Daily
Refresh
“We reach accounts the week they land in-market — not the quarter after.”
Head of Growth · a 500+ revenue team on Pubrio

See the world’s companies move.

Book a walkthrough of the movement map with our team.

pubrio

Pubrio glocalizes business, people, and intent data from 50+ local sources into one global graph, giving AI and revenue teams full‑market visibility.​

© 2026 Pubrio. All rights reserved.